hypertension

On a conference call, the firm's CEO said that it and other industry players are pushing to postpone implementation of PAMA to no earlier than July 1, 2018. 

This Week in PLOS

In PLOS this week: blood pressure and hypertension loci in people of African ancestry, Plasmodium vivax population genomics, and more.

Geneticure has raised around $1.1 million to fund the study, which may very well be the largest prospective RCT for personalization of high blood pressure treatment.

This Week in Nature

In Nature this week: a CRISPR/Cas9 system that can be toggled, and more.

Tapping data for hundreds of thousands of individuals, three teams uncovered overlaps between blood pressure and other metabolic and immune traits.

The researchers demonstrated that blocking the functioning of certain genes expanded the lifespan of lab animals.

Variants at 12 loci associated with blood pressure traits in European, East Asian, and South Asian individuals overlap with apparent DNA methylation regulators.

A meta-analysis of blood expression data for more than 7,000 individuals highlighted 34 transcripts with blood pressure-associated expression patterns.

The study shines light on the population history of sub-Saharan Africa and provides the basis for future medical genetics studies, including a new pan-African genotype array.

NEW YORK (GenomeWeb) – People armed with genetic information about their risk for developing high blood were more inclined to cut down on their salt intake, researchers from the University of Toronto reported in a study

Pages

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.